Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.53
Delayed Data
As of 4:00pm ET
 -0.23 / -4.83%
Today’s Change
3.92
Today|||52-Week Range
8.38
-2.58%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close4.76
Today’s open4.75
Day’s range4.47 - 4.75
Volume1,160,722
Average volume (3 months)1,316,720
Market cap$593.5M
Data as of 4:00pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+5.92%
Earnings growth (this year)+58.25%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+89.60%
P/E ratioNM
Price/Sales8.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc-0.20-0.76%
TGTXTG Therapeutics Inc-0.35-2.43%
BYSIBeyondspring Inc-1.10-3.54%
EGRXEagle Pharmaceutical...+0.08+0.15%
Data as of 4:00pm ET, 04/23/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$60.6M
Annual profit (last year)-$163.4M
Net profit margin-269.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts